抗周期素依賴性激酶2(CDK2)多克隆抗體
Anti-Cyclin Dependent Kinase 2 (CDK2) Polyclonal Antibody
CDKN2; p33(CDK2); Cell division protein kinase 2; p33 protein kinase
- 編號FAB889Mu01
- 物種Mus musculus (Mouse，小鼠)相同的名稱，不同的物種。
- 效價-
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 激發(fā)波長
- 單次使用量
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 且適物種Mus musculus (Mouse，小鼠)
- 應(yīng)用FCM
- 下載英文說明書 中文說明書
- 規(guī)格25test50test100test200test500test
- 價格暫無報價暫無報價暫無報價暫無報價暫無報價
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Human Hela cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 20μg/ml rabbit Anti-mouse CDK2 Polyclonal Antibody (Catalog FAB889Mu01, red histogram) or Isotype control antibody (Catalog IS067-Rb01, green histogram), followed by 1μg/ml FITC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog SAA544Rb18).
通過ISO 9001、ISO 13485質(zhì)量體系認證
用法
Flow cytometry: 20μg/ml;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過一年。避免反復(fù)凍融。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB889Mu01 | 周期素依賴性激酶2(CDK2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB889Mu03 | 周期素依賴性激酶2(CDK2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB889Mu02 | 周期素依賴性激酶2(CDK2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB889Mu01 | 周期素依賴性激酶2(CDK2)多克隆抗體 | WB; IHC; ICC/IF |
| PAB889Mu02 | 周期素依賴性激酶2(CDK2)多克隆抗體 | WB |
| PAB889Mu03 | 周期素依賴性激酶2(CDK2)多克隆抗體 | WB |
| FAB889Mu01 | 抗周期素依賴性激酶2(CDK2)多克隆抗體 | FCM |
| LAB889Mu71 | 周期素依賴性激酶2(CDK2)多克隆抗體(生物素標記) | WB; IHC; ICC. |
參考文獻
| 雜志 | 參考文獻 |
| Leukemia & Lymphoma | The nanoparticulate Quillaja saponin KGI exerts anti-proliferative effects by down-regulation of cell cycle molecules in U937 and HL-60 human leukemia cells[Pubmed: 24138332] |
| Future Medicinal Chemistry | Construction of some cytotoxic agents with aurone and furoaurone scaffolds[pubmed:29235893] |
| Synthesis of Novel Heterocyclic Compounds Containing Benzothiophene of Expected Anticancer Activity.[:] |